Nurse practitioner-led program to help hospitalized smokers quit
Official title: Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers With Cardiopulmonary Disease
Run by Baystate Medical Center · NCT05733767 · Data updated 2026-11-12
This study tests a program led by nurse practitioners to help hospitalized smokers with heart and lung issues quit smoking by using better medications and support.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 424 (estimated) |
| Sponsor | Baystate Medical Center Academic / other |
| Locations | 1 site (Springfield, Massachusetts) |
| Status | Recruiting |
| Started | November 3, 2022 |
| Main results expected | August 28, 2027 |
| Study ends | December 30, 2027 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT05733767 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are hospitalized patients at Baystate Medical Center with a diagnosis of a cardiopulmonary condition who smoke cigarettes.
✕Probably not a fit
Patients who are pregnant, nursing, have suicidal ideation, or are expected to have a short life expectancy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a nurse practitioner-led tobacco treatment team aimed at improving smoking cessation pharmacotherapy among hospitalized patients with cardiopulmonary conditions. Patients admitted to Baystate Medical Center who smoke will be screened and randomized into either enhanced usual care or the intervention group. The primary goal is to increase the use of guideline-concordant smoking cessation medications and improve smoking cessation rates at six months post-discharge. The study will recruit 424 patients to assess the effectiveness of this intervention.
Why it matters
Potential benefit: If successful, this approach could significantly increase smoking cessation rates among hospitalized patients, leading to improved health outcomes.
How similar studies have gone: Other studies have shown success with similar interventions aimed at smoking cessation in hospitalized patients, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Admitted to Baystate Medical Center in Springfield, MA with a cardiac or pulmonary disease diagnosis will be eligible to participate in this trial. * Patients who smoke cigarettes * Speak English We will include any patients with the following diagnoses or procedures from Baystate Medical Center in Springfield, MA: * myocardial infarction * coronary artery bypass grafting surgery * heart valve surgery * percutaneous coronary intervention (PCI) * acute coronary syndrome * heart failure * chronic obstructive pulmonary disease (COPD) * asthma exacerbation. Exclusion Criteria: * We will exclude pregnant or nursing women, patients with current suicidal ideation, planned discharge to hospice or expected survival \<6 months, or concurrent use of daily smoked marijuana, because this can increase exhaled carbon monoxide levels, which would confound biochemical confirmation.
Where it's running
-
Baystate Medical Center
Springfield, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Quinn R Pack, MD — Baystate Medical Center
- Study coordinator: Quinn R Pack, MD
- Email: quinn.pack@baystatehealth.org
- Phone: 413-794-4490
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Quitting Matters: a smoking quit program for people living with HIV
This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.
-
Smoky Futures: Danish Adolescent Nicotine Use over Time
This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.
-
Nicotine Orodispersible Tablet to Relieve Cravings in Smokers
A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.
-
Optimizing when weekly chatbot reminders go out to people using a chatbot for quitting smoking
This study tests whether sending weekly reminders at different times helps people stay engaged with a chatbot smoking-cessation service.
-
NMDA and Sigma-1 combination therapy for smoking cessation with AXS-05
This phase 3 trial tests whether AXS-05 can help adults quit smoking better than placebo or bupropion.
-
AI-assisted interactive case-based training to improve smoking cessation counseling by medical interns
This study tests whether AI-powered interactive case-based training helps medical interns provide better smoking cessation counseling.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.